CryoCath Voluntary Catheter Replacement To Result In $1.5 Mil. Charge
This article was originally published in The Gray Sheet
Executive Summary
CryoCath voluntarily will replace certain obsolete 7 Fr cryotherapy catheters that have demonstrated a breakage rate of less than 0.5% in over 4,000 procedures to date, the company says
You may also be interested in...
CryoCath Freezor Tachycardia Approval Includes Cryomapping Indication
CryoCath says it will pursue an expanded indication for its Freezor cardiac cryoablation system to address epicardial posteroseptal accessory atrioventricular pathways
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.